Part 9: Post-cardiac Arrest Care: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care
Overview
Authors
Affiliations
The goal of immediate post-cardiac arrest care is to optimize systemic perfusion, restore metabolic homeostasis, and support organ system function to increase the likelihood of intact neurological survival. The post-cardiac arrest period is often marked by hemodynamic instability as well as metabolic abnormalities. Support and treatment of acute myocardial dysfunction and acute myocardial ischemia can increase the probability of survival. Interventions to reduce secondary brain injury, such as therapeutic hypothermia, can improve survival and neurological recovery. Every organ system is at risk during this period, and patients are at risk of developing multiorgan dysfunction. The comprehensive treatment of diverse problems after cardiac arrest involves multidisciplinary aspects of critical care, cardiology, and neurology. For this reason, it is important to admit patients to appropriate critical-care units with a prospective plan of care to anticipate, monitor, and treat each of these diverse problems. It is also important to appreciate the relative strengths and weaknesses of different tools for estimating the prognosis of patients after cardiac arrest.
Examining safety of cardiac surgery in patients with preoperative cardiac arrest.
Vadlakonda A, Bakhtiyar S, Ebrahimian S, Sakowitz S, Chervu N, Verma A PLoS One. 2025; 20(3):e0319563.
PMID: 40067831 PMC: 11896030. DOI: 10.1371/journal.pone.0319563.
Tsoungani G, Nour S Arch Acad Emerg Med. 2025; 13(1):e30.
PMID: 40027223 PMC: 11868666. DOI: 10.22037/aaemj.v13i1.2447.
Extracorporeal Cardiopulmonary Resuscitation-Where Do We Currently Stand?.
Ferrell B, Thomas J, Skendelas J, Uehara M, Sugiura T Biomedicines. 2025; 13(1).
PMID: 39857787 PMC: 11759854. DOI: 10.3390/biomedicines13010204.
Individualized autoregulation-guided arterial blood pressure management in neurocritical care.
Gomez J, Bhende B, Mathur R, Gonzalez L, Shah V Neurotherapeutics. 2025; 22(1):e00526.
PMID: 39828496 PMC: 11840358. DOI: 10.1016/j.neurot.2025.e00526.
Inoue Y, Okamura K, Shimada H, Watakabe S, Hirayama S, Hirata M J Clin Med Res. 2025; 16(12):578-588.
PMID: 39759487 PMC: 11699870. DOI: 10.14740/jocmr6111.